Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Cinchonine

Copy Product Info
😃Good
Catalog No. T0012Cas No. 118-10-5
Alias LA40221, (8R,9S)-Cinchonine

Cinchonine (LA40221), a local anesthetic of the amide type, now generally used for surface anesthesia. It is one of the most potent and toxic of the long-acting local narcotics and its parenteral use is restricted to spinal anesthesia.

Cinchonine

Cinchonine

Copy Product Info
😃Good
Purity: 99.45%
Catalog No. T0012Alias LA40221, (8R,9S)-CinchonineCas No. 118-10-5
Cinchonine (LA40221), a local anesthetic of the amide type, now generally used for surface anesthesia. It is one of the most potent and toxic of the long-acting local narcotics and its parenteral use is restricted to spinal anesthesia.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
5 g$29-In Stock
1 mL x 10 mM (in DMSO)$29In StockIn Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.45%
Appearance:Solid
Color:White
Contact us for more batch information

Resource Download

Product Introduction

Cinchonine AI Summary
Cinchonine exhibits multifaceted bioactivities, prominently displaying significant antimalarial properties against various strains of Plasmodium falciparum, including chloroquine-sensitive (3D7) and chloroquine-resistant (W2 and K1) strains, with low IC50 values ranging from 21.0 to 220.0 nM. The compound also inhibits parasite development in erythrocytes and heme polymerization in Plasmodium falciparum. It shows moderate cytotoxicity against human cell lines, including hepatocellular carcinoma (Huh7) and WI38 cells, with high selectivity indices. Additionally, Cinchonine exhibits potent inhibition of various targets including HIV1 reverse transcriptase, acetylcholinesterase, butyrylcholinesterase, SKCa channels, and cytochrome P450 2D6. It also demonstrates significant activity in antitrypanosomal, antileishmanial, lipid storage modulation, Nrf2 screening, and inhibition of microbial strains and SARS-CoV-2 viral activities..
Note: Summary generated by AI. Data source: ChEMBL
Bioactivity
Description
Cinchonine (LA40221), a local anesthetic of the amide type, now generally used for surface anesthesia. It is one of the most potent and toxic of the long-acting local narcotics and its parenteral use is restricted to spinal anesthesia.
Targets&IC50
P-gp:
SynonymsLA40221, (8R,9S)-Cinchonine
Chemical Properties
Molecular Weight294.39
FormulaC19H22N2O
Cas No.118-10-5
Smiles[C@@H](O)([C@@]1([N@@]2C[C@H](C=C)[C@](C1)(CC2)[H])[H])C=3C4=C(N=CC3)C=CC=C4
Relative Density.Ca. 130 kg/m3.
Storage & Solubility Information
StorageIn solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 2.95 mg/mL (10.02 mM), Sonication is recommended.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM3.3969 mL16.9843 mL33.9685 mL169.8427 mL
5 mM0.6794 mL3.3969 mL6.7937 mL33.9685 mL
10 mM0.3397 mL1.6984 mL3.3969 mL16.9843 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Cinchonine | purchase Cinchonine | Cinchonine cost | order Cinchonine | Cinchonine chemical structure | Cinchonine formula | Cinchonine molecular weight